Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
NurExone Biologic Inc. (NRXBF) had Return on Equity of -100.55% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-1.47M |
|
-- |
|
-- |
|
$1.47M |
|
$-1.47M |
|
$0.00M |
|
$-1.47M |
|
$-1.47M |
|
$-1.47M |
|
$-1.47M |
|
$-1.47M |
|
$-1.47M |
|
$-1.47M |
|
$-1.42M |
|
77.59M |
|
77.59M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$1.15M |
|
$0.76M |
|
$1.50M |
|
$2.65M |
|
$0.86M |
|
-- |
|
$0.33M |
|
$1.19M |
|
$1.46M |
|
$1.46M |
|
$1.46M |
|
82.46M |
|
| Cash Flow Statement Financials | |
$-3.34M |
|
$-0.05M |
|
$3.56M |
|
$0.70M |
|
$0.98M |
|
$0.28M |
|
$0.95M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.33 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.38M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-100.55% |
-100.55% |
|
-55.37% |
|
-100.55% |
|
$0.02 |
|
$-0.04 |
|
$-0.04 |
|